StemWave Introduces Modus-F, A New FDA Listed Device With Cellular Response Therapy (CRT) Now Available For Orthopedic Use
March 28, 2022 – StemWave recently announced that their newest device Modus-F is now available for sale. StemWave recently received a Class l listing from the FDA and announced an exclusive North American partnership with Inceler Medikal, a leading global manufacturer. StemWave’s newest product, Modus-F, uses uniquely designed Cellular Response Therapy (CRT) which utilizes an […]
